New drug cocktail shows promise for aggressive breast cancer
Disease control
Ongoing
This study tests a combination of two drugs, ribociclib and bicalutamide, in people with advanced triple-negative breast cancer that has a specific marker (androgen receptor). The goal is to see if the combo can shrink tumors or stop them from growing. 37 participants are enrolle…
Phase: PHASE1, PHASE2 • Sponsor: Kari Wisinski • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC